丹麦急性肾损伤发病与预后的地区差异
该研究利用丹麦全国医疗数据库识别2017年成人AKI患者,按地区与市镇类别分析发病率、CKD、全因死亡、生化随访及肾内科门诊随访的差异。标准化AKI发病率各区间为12.9至14.9/1000人年,死亡率相近,但CKD、生化随访和肾内科随访存在地区差异。
要点
- 丹麦各区间标准化AKI发病率差异有限,为12.9至14.9/1000人年。
- AKI后全因死亡各区间aHR为0.97至1.04,地区间基本一致。
- AKI后CKD与肾内科随访的地区差异较明显,提示照护不均衡。
核心结论
- 在统一医疗体系内,丹麦AKI发病率地区差异有限,AKI后死亡相似,但CKD、生化随访和肾内科随访存在地区与市镇类别差异。
研究设计与样本
- 基于丹麦全国医疗数据库的队列研究,利用覆盖全部居民的肌酐检测识别2017年AKI患者。
- 共识别58 356名成人的63 382次AKI发作。
- 按市镇估算粗率与性别年龄标准化发病率,并跨地区及市镇类别估算调整风险比。
主要发现
- 各区间标准化AKI发病率为12.9至14.9/1000人年。
- 以首都大区为参照,CKD的aHR各区间为1.04至1.25,全因死亡为0.97至1.04。
- 生化随访的aHR各区间为1.09至1.15,肾内科门诊随访为1.08至1.49。
- 市镇类别间亦见类似差异。
关键数值与推荐
- 标准化AKI发病率区间范围:12.9至14.9/1000人年。
- CKD的aHR区间:1.04至1.25;全因死亡:0.97至1.04;生化随访:1.09至1.15;肾内科门诊随访:1.08至1.49(均以首都大区为参照)。
临床怎么用
- 提示肾内科应关注AKI后CKD监测与随访的地区不均衡,优化随访资源配置。
- 可参考地区差异评估本地AKI后生化与肾内科随访的落实质量。
局限性
- 原文摘要未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Examining regional variation in acute kidney injury (AKI) and associated outcomes may reveal inequalities and possibilities for optimization of the quality of care. Using the Danish medical databases, we examined regional variation in the incidence, follow-up and prognosis of AKI in Denmark. METHODS: Patients with one or more AKI episodes in 2017 were identified using population-based creatinine measurements covering all Danish residents. Crude and sex-and-age-standardized incidence rates of AKI were estimated using census statistics for each municipality. Adjusted hazard ratios (aHR) of chronic kidney disease (CKD), all-cause death, biochemical follow-up and outpatient contact with a nephrology department after AKI were estimated across geographical regions and categories of municipalities, accounting for differences in demographics, comorbidities, medication use, lifestyle and social factors, and baseline kidney function. RESULTS: We identified 63 382 AKI episodes in 58 356 adults in 2017. The regional standardized AKI incidence rates ranged from 12.9 to 14.9 per 1000 person-years. Compared with the Capital Region of Denmark, the aHRs across regions ranged from 1.04 to 1.25 for CKD, from 0.97 to 1.04 for all-cause death, from 1.09 to 1.15 for biochemical follow-up and from 1.08 to 1.49 for outpatient contact with a nephrology department after AKI. Similar variations were found across municipality categories. CONCLUSIONS: Within the uniform Danish healthcare system, we found modest regional variation in AKI incidence. The mortality after AKI was similar; however, CKD, biochemical follow-up and nephrology follow-up after AKI varied across regions and municipality categories.
引用
- Jensen SK, Rasmussen TB, Jacobsen BH, et al. Regional variation in incidence and prognosis of acute kidney injury. Nephrol Dial Transplant. 2024. PMID: 38140955. doi:10.1093/ndt/gfad267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。